Literature DB >> 19843976

Brain-derived neurotrophic factor signaling modulates cocaine induction of reward-associated ultrasonic vocalization in rats.

Stacey N Williams1, Ashiwel S Undieh.   

Abstract

Cocaine exhibits high liability for inducing addictive behaviors, but the mechanisms of neuroplasticity underlying the behavioral effects remain unclear. As a crucial mediator of neuroplasticity in diverse functional models, brain-derived neurotrophic factor (BDNF) could contribute to the mechanisms of addiction-related neuroplasticity. Here, we addressed the hypothesis that cocaine increases synaptic dopamine, which induces BDNF protein expression to initiate addiction-related behavior in the rat. An enzyme-linked immunosorbent assay was used to measure BDNF protein expression in rat striatal tissues. For behavioral readout, we used a noninvasive measurement system to measure the emission of 50-kHz ultrasonic vocalization (USV), a response that correlates with electrical brain stimulation and conditioned place preference behavior in rodents. A single injection of cocaine significantly increased BDNF protein expression, but this effect was not further augmented by repeated cocaine administration. A single administration of cocaine elicited significant and dose-related USV responses, and the magnitude of the behavior increased with repeated drug administration. R-(+)-7-Chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine (SCH23390), but not raclopride, significantly attenuated cocaine-induced BDNF protein expression, whereas either the D(1)-like or D(2)-like receptor antagonist blocked cocaine-induced USV behavior. Furthermore, significant USV behavior was elicited by the nonselective dopamine agonist, apomorphine, but not by agonists that are selective for D(1)-like or D(2)-like receptors. Intracerebroventricular injection of the neurotrophin TrkB receptor inhibitor, K252a, blocked cocaine-induced USV behavior but not locomotor activity. These results suggest that neurotrophin signaling downstream of dopamine receptor function probably constitutes a crucial link in cocaine induction of USV behavior and may contribute to the mechanisms underlying the development of addiction-related behaviors.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19843976      PMCID: PMC2812116          DOI: 10.1124/jpet.109.158535

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  40 in total

1.  Rodent BDNF genes, novel promoters, novel splice variants, and regulation by cocaine.

Authors:  Qing-Rong Liu; Lin Lu; Xu-Guang Zhu; Jian-Ping Gong; Yavin Shaham; George R Uhl
Journal:  Brain Res       Date:  2005-12-22       Impact factor: 3.252

Review 2.  The neural basis of addiction: a pathology of motivation and choice.

Authors:  Peter W Kalivas; Nora D Volkow
Journal:  Am J Psychiatry       Date:  2005-08       Impact factor: 18.112

3.  Amphetamine-induced 50 kHz calls from rat nucleus accumbens: a quantitative mapping study and acoustic analysis.

Authors:  Briar Thompson; Kevin C Leonard; Stefan M Brudzynski
Journal:  Behav Brain Res       Date:  2005-12-15       Impact factor: 3.332

4.  Cocaine induction of ERK proteins in dorsal striatum of Fischer rats.

Authors:  Shirzad Jenab; Eugene D Festa; Arbi Nazarian; Hui Bing K Wu; Wei Lun Sun; Ruhal Hazim; Scott J Russo; Vanya Quinones-Jenab
Journal:  Brain Res Mol Brain Res       Date:  2005-11-04

Review 5.  Cocaine-induced alterations in dopamine receptor signaling: implications for reinforcement and reinstatement.

Authors:  S M Anderson; R C Pierce
Journal:  Pharmacol Ther       Date:  2005-02-26       Impact factor: 12.310

6.  Enhancement of locomotor activity and conditioned reward to cocaine by brain-derived neurotrophic factor.

Authors:  B A Horger; C A Iyasere; M T Berhow; C J Messer; E J Nestler; J R Taylor
Journal:  J Neurosci       Date:  1999-05-15       Impact factor: 6.167

7.  The role of dopamine receptor subtypes in the discriminative stimulus effects of amphetamine and cocaine in rats.

Authors:  M Filip; E Przegaliński
Journal:  Pol J Pharmacol       Date:  1997 Jan-Feb

8.  A single cocaine exposure increases BDNF and D3 receptor expression: implications for drug-conditioning.

Authors:  Bernard Le Foll; Jorge Diaz; Pierre Sokoloff
Journal:  Neuroreport       Date:  2005-02-08       Impact factor: 1.837

9.  Regulation of a protein phosphatase cascade allows convergent dopamine and glutamate signals to activate ERK in the striatum.

Authors:  Emmanuel Valjent; Vincent Pascoli; Per Svenningsson; Surojit Paul; Hervé Enslen; Jean-Christophe Corvol; Alexandre Stipanovich; Jocelyne Caboche; Paul J Lombroso; Angus C Nairn; Paul Greengard; Denis Hervé; Jean-Antoine Girault
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-17       Impact factor: 11.205

10.  PI3 kinase is involved in cocaine behavioral sensitization and its reversal with brain area specificity.

Authors:  Xiuwu Zhang; Jing Mi; William C Wetsel; Colin Davidson; Xieying Xiong; Qiang Chen; Everett H Ellinwood; Tong H Lee
Journal:  Biochem Biophys Res Commun       Date:  2005-12-28       Impact factor: 3.322

View more
  30 in total

1.  Cocaine alters BDNF expression and neuronal migration in the embryonic mouse forebrain.

Authors:  Deirdre M McCarthy; Xuan Zhang; Shayna B Darnell; Gavin R Sangrey; Yuchio Yanagawa; Ghazaleh Sadri-Vakili; Pradeep G Bhide
Journal:  J Neurosci       Date:  2011-09-21       Impact factor: 6.167

2.  Dopamine-sensitive signaling mediators modulate psychostimulant-induced ultrasonic vocalization behavior in rats.

Authors:  Stacey N Williams; Ashiwel S Undieh
Journal:  Behav Brain Res       Date:  2015-08-11       Impact factor: 3.332

3.  Assessing the role of dopamine in limb and cranial-oromotor control in a rat model of Parkinson's disease.

Authors:  Jacqueline R Kane; Michelle R Ciucci; Amber N Jacobs; Nathan Tews; John A Russell; Allison M Ahrens; Sean T Ma; Joshua M Britt; Lawrence K Cormack; Timothy Schallert
Journal:  J Commun Disord       Date:  2011-04-30       Impact factor: 2.288

4.  Alcohol-naïve USVs distinguish male HAD-1 from LAD-1 rat strains.

Authors:  Nitish Mittal; Neha Thakore; James M Reno; Richard L Bell; W Todd Maddox; Timothy Schallert; Christine L Duvauchelle
Journal:  Alcohol       Date:  2017-09-14       Impact factor: 2.405

5.  Dose-dependent differences in short ultrasonic vocalizations emitted by rats during cocaine self-administration.

Authors:  David J Barker; David H Root; Sisi Ma; Shaili Jha; Laura Megehee; Anthony P Pawlak; Mark O West
Journal:  Psychopharmacology (Berl)       Date:  2010-06-23       Impact factor: 4.530

6.  Amphetamine-induced appetitive 50-kHz calls in rats: a marker of affect in mania?

Authors:  Marcela Pereira; Roberto Andreatini; Rainer K W Schwarting; Juan C Brenes
Journal:  Psychopharmacology (Berl)       Date:  2014-01-11       Impact factor: 4.530

7.  The role of dopaminergic transmission through D1-like and D2-like receptors in amphetamine-induced rat ultrasonic vocalizations.

Authors:  Jennifer M Wright; May R S Dobosiewicz; Paul B S Clarke
Journal:  Psychopharmacology (Berl)       Date:  2012-09-28       Impact factor: 4.530

8.  α- and β-Adrenergic receptors differentially modulate the emission of spontaneous and amphetamine-induced 50-kHz ultrasonic vocalizations in adult rats.

Authors:  Jennifer M Wright; May R S Dobosiewicz; Paul B S Clarke
Journal:  Neuropsychopharmacology       Date:  2011-10-26       Impact factor: 7.853

9.  Diazepam blocks 50 kHz ultrasonic vocalizations and stereotypies but not the increase in locomotor activity induced in rats by amphetamine.

Authors:  Gisele de Oliveira Guaita; Debora Dalla Vecchia; Roberto Andreatini; Donita L Robinson; Rainer K W Schwarting; Claudio Da Cunha
Journal:  Psychopharmacology (Berl)       Date:  2018-03-23       Impact factor: 4.530

10.  Individual differences in the conditioned and unconditioned rat 50-kHz ultrasonic vocalizations elicited by repeated amphetamine exposure.

Authors:  Allison M Ahrens; Cameron W Nobile; Lindsay E Page; Esther Y Maier; Christine L Duvauchelle; Timothy Schallert
Journal:  Psychopharmacology (Berl)       Date:  2013-05-23       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.